Focus: Denali Therapeutics is a 5,000+ employee biotechnology company headquartered in South San Francisco specializing in neurodegenerative disease therapies with proprietary blood-brain barrier-crossing antibody technology.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Stable — net +3 jobs in 30d
4 added, 1 removed. Backfill posture.
Best fit for biotech scientists and clinical professionals committed to neurodegenerative disease research with tolerance for early-stage risk; less attractive for near-term revenue growth plays or those seeking maximum job stability.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Denali Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Denali Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Denali Therapeutics Inc. (DNLI) Stock Price, News, Quote & History - Yahoo! Finance Canada
Denali Therapeutics Inc. (DNLI) Stock Price, News, Quote & History Yahoo! Finance Canada
Denali Therapeutics Inc. (DNLI) stock price, news, quote and history - Yahoo Finance UK
Denali Therapeutics Inc. (DNLI) stock price, news, quote and history Yahoo Finance UK
Denali Therapeutics Inc. (DNLI) latest stock news and headlines - Yahoo Finance UK
Denali Therapeutics Inc. (DNLI) latest stock news and headlines Yahoo Finance UK
Denali Therapeutics (NasdaqGS:DNLI) Stock Forecast & Analyst Predictions - Simply Wall Street
Denali Therapeutics (NasdaqGS:DNLI) Stock Forecast & Analyst Predictions Simply Wall Street
Denali Therapeutics Stock Price Forecast. Should You Buy DNLI? - StockInvest.us
Denali Therapeutics Stock Price Forecast. Should You Buy DNLI? StockInvest.us
Transcript : Denali Therapeutics Inc. Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference, Sep-09-2026 09 - www.marketscreener.com
Transcript : Denali Therapeutics Inc. Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference, Sep-09-2026 09 www.marketscreener.com
Showing 6 of 10 news items
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Source: state DOL filings, aggregated via Big Local News
Recent layoff indicates operational tightening despite $5B+ market cap, raising questions about pipeline confidence or cash burn trajectory.
Recent peer-reviewed publications with author affiliations at this company
Executive functions are independently associated with health-related numeracy and self-perceived health literacy in applied contexts in healthy adults.
Hitching a Ride to Overcome Barriers: Nonclinical Safety Considerations for Bioconjugated Oligonucleotides.
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo